JGGDR
JGP Global Gestao de Recursos Portfolio holdings
AUM
$204M
This Quarter Return
+9.43%
1 Year Return
+109.69%
3 Year Return
+285.93%
5 Year Return
+345.7%
10 Year Return
+378.07%
AUM
$95.3M
AUM Growth
+$95.3M
(-31%)
Cap. Flow
-$503M
Cap. Flow
% of AUM
-528.35%
Top 10 Holdings %
Top 10 Hldgs %
79.51%
Holding
73
New
12
Increased
18
Reduced
21
Closed
17
Top Buys
| 1 |
KraneShares CSI China Internet ETF
KWEB
|
$17.8M |
| 2 |
Walt Disney
DIS
|
$11.2M |
| 3 |
Stryker
SYK
|
$5.17M |
| 4 |
Salesforce
CRM
|
$4.45M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
$4.13M |
Top Sells
Sector Composition
| 1 | Technology | 26.9% |
| 2 | Healthcare | 25.97% |
| 3 | Communication Services | 12.09% |
| 4 | Financials | 7.51% |
| 5 | Materials | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
YPF
YPF
$12B
| $481K | 0.5% |
+1,526
| New | +$481K |
|
27
Amazon
AMZN
$2.44T
| $434K | 0.45% |
4,200
-4,300
| -51% | -$444K |
|
|
LOMA
28
Loma Negra
LOMA
$1.09B
| $424K | 0.44% |
+13,587
| New | +$424K |
|
29
Incyte
INCY
$16.5B
| $412K | 0.43% |
848
-12,340
| -94% | -$5.99M |
|
30
Alnylam Pharmaceuticals
ALNY
$58.5B
| $379K | 0.39% |
1,892
+159
| +9% | +$31.9K |
|
31
Agilent Technologies
A
$35.7B
| $374K | 0.39% |
2,702
+77
| +3% | +$10.7K |
|
32
Regeneron Pharmaceuticals
REGN
$61.5B
| $357K | 0.37% |
8,759
+8,093
| +1,215% | +$330K |
|
33
Becton Dickinson
BDX
$55.3B
| $349K | 0.36% |
1,410
-3
| -0.2% | -$743 |
|
|
VLATU
34
DELISTED
Valor Latitude Acquisition Corp. Unit
VLATU
| $342K | 0.35% |
1,700
-1,098,300
| -100% | -$221M |
|
35
AbbVie
ABBV
$372B
| $337K | 0.35% |
2,112
-544
| -20% | -$86.7K |
|
36
Acadia Pharmaceuticals
ACAD
$4.38B
| $308K | 0.32% |
16,380
-359
| -2% | -$6.76K |
|
37
Galicia Financial Group
GGAL
$6.31B
| $291K | 0.3% |
3,000
-322,000
| -99% | -$31.2M |
|
38
BioMarin Pharmaceuticals
BMRN
$11.2B
| $264K | 0.27% |
2,713
| – | – |
|
39
Eletrobras Common Shares
EBR
$18.5B
| $257K | 0.27% |
+4,070
| New | +$257K |
|
40
JD.com
JD
$44.1B
| $256K | 0.27% |
+52,535
| New | +$256K |
|
41
Ascendis Pharma
ASND
$11.8B
| $249K | 0.26% |
2,325
+49
| +2% | +$5.25K |
|
|
OIBR.C
42
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $249K | 0.26% |
931
-574,069
| -100% | -$154M |
|
43
Pfizer
PFE
$141B
| $234K | 0.24% |
841
-8,428
| -91% | -$2.35M |
|
44
Danaher
DHR
$147B
| $222K | 0.23% |
869
-1,995
| -70% | -$510K |
|
45
Merck
MRK
$210B
| $219K | 0.23% |
6,759
+2,029
| +43% | +$65.6K |
|
46
Humana
HUM
$36.5B
| $204K | 0.21% |
774
-140
| -15% | -$36.9K |
|
47
Cigna
CI
$80.3B
| $186K | 0.19% |
28,032
+27,113
| +2,950% | +$180K |
|
48
Banco Bradesco
BBD
$32.9B
| $115K | 0.12% |
+44,000
| New | +$115K |
|
|
SGEN
49
DELISTED
Seagen Inc. Common Stock
SGEN
| $7.25K | 0.01% |
160,000
+142,272
| +803% | +$6.45K |
|
50
Pampa Energía
PAM
$3.67B
| $2.07K | ﹤0.01% |
+575,000
| New | +$2.07K |
|